UBLITUXIMAB for Relapsing multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where UBLITUXIMAB was used for Relapsing multiple sclerosis.
Most Reported Side Effects for UBLITUXIMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 538 | 34.0% | 0 | 21 |
| Fatigue | 110 | 7.0% | 1 | 9 |
| Headache | 55 | 3.5% | 1 | 5 |
| Inappropriate schedule of product administration | 53 | 3.4% | 1 | 0 |
| Malaise | 49 | 3.1% | 0 | 3 |
| Multiple sclerosis relapse | 48 | 3.0% | 1 | 18 |
| Asthenia | 45 | 2.8% | 0 | 7 |
| Pain | 45 | 2.8% | 0 | 5 |
| Illness | 43 | 2.7% | 0 | 4 |
| Urinary tract infection | 42 | 2.7% | 2 | 13 |
| Covid-19 | 39 | 2.5% | 1 | 11 |
| Gait disturbance | 37 | 2.3% | 0 | 5 |
| Nasopharyngitis | 37 | 2.3% | 1 | 3 |
| Nausea | 37 | 2.3% | 1 | 4 |
| Pain in extremity | 37 | 2.3% | 1 | 7 |
Other Indications for UBLITUXIMAB
Multiple sclerosis (1,455)
Chronic lymphocytic leukaemia (62)
Non-hodgkin's lymphoma (17)
Product used for unknown indication (12)
B-cell lymphoma (7)
Follicular lymphoma (5)
Other Drugs Used for Relapsing multiple sclerosis
OCRELIZUMAB (6,883)
OFATUMUMAB (3,705)
FINGOLIMOD (851)
GLATIRAMER (375)
ALEMTUZUMAB (350)
SIPONIMOD (194)
INTERFERON BETA-1A (192)
NATALIZUMAB (140)
RITUXIMAB (136)
OZANIMOD (127)